FDA
-
-
-
-
-
-
-
Surmodics Announces PROWL Registry Sex-Specific Data to be Presented at TCT Conference on October 28
-
-
-
-
-
-
-
Surmodics Reports First Quarter of Fiscal Year 2025 Financial Results
-
-
-
-
-
-
-
Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
-
-
-
-
-
-
-
SurModics (SRDX) Granted FDA Approval for the SurVeil Drug-Coated Balloon
-
-
-
-
-
-
-
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX
-
-
-
-
-
-
-
24-Month Data from Surmodics’ TRANSCEND Trial Presented at VIVA 2022 Conference
-
-
-
-
-
-
-
Dr. Gary Ansel to Present Pounce™ Thrombectomy System First-in-Human Data at Charing Cross Symposium
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

